ICYMI (MBJ): UTHSC getting $5 million for cancer research
The National Cancer Institute recently awarded a $1.75 million grant to a University of Tennessee Health Science Center professor to study colorectal cancer. That comes on the heels of another $3.4 million in grants to study pancreatic cancer.
Dr. Subhash Chauhan, a professor in the Departments of Pharmaceutical Sciences in the College of Pharmacy and Pathology in the College of Medicine, will study the pathogenesis of colorectal cancer, the second deadliest cancer, which disproportionately affects people of African-American and Native American descent.
The $1.75 million grant will be distributed over the next five years.
Colorectal cancer affects more than 1 million people every year. A recent study has identified three main hot spots in the United States, the highest being in the Mississippi Delta region, which has a rate 40 percent higher than rest of the country. It is not known why the disease is more common in these areas. The research could aid in the understanding of the beginning stages of colorectal cancer, and help identify new biomarkers that can be used for early stage diagnosis, metastasis and drug response.